Screen Shot 2018-03-19 at 13.47.21.png
Peter Jensen Non-Executive Chairman

Peter is responsible for the leadership of the Board, ensuring its effectiveness and setting its agenda. Peter held a number of senior positions in his 21 years with SmithKline-Beecham, including Chairman of Consumer Healthcare and President of Worldwide Supply Operations.

He has previously held Non-executive or Chairman roles at a number of public and private companies including Domino Printing Sciences plc, Glenmorangie plc and Genetix Group plc.

External Appointments
Chairman Sandown Park Racecourse
Screendragon (Software) Limited
Home of Horseracing Trust Limited
British Sporting Art Trust
Trustee of National Horseracing Museum

A N*

Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee

Screen Shot 2018-03-19 at 13.53.23.png
Stephen Smith Non-Executive Director

Stephen is a Chartered Management Accountant, Fellow of the Association of Corporate Treasurers and member of the Institute for Turnaround. During his career he held a number of financial roles in UK listed companies. Since 1995 he has operated as an independent executive and has since taken on a number of boards, advisory or executive roles.

External Appointments
Roles include Chairman of Tensator Holdings Limited, Rio Laranja Holdings Limited, Icknield Limited and Non-Executive Director of EAT Limited.

A* N R*

Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee

Screen Shot 2018-03-19 at 13.55.06.png
Tunde Otulana Non-Executive Director

Tunde is Senior Vice President and Chief Medical Officer at Mallinckrodt Pharmaceuticals where he has responsibility for all global medical functions. His career includes leadership roles at Boehringer Ingelheim Pharmaceutical Inc. and the US Food and Drug Administration (FDA).

External Appointments
None

N R

Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee

Screen Shot 2018-03-19 at 13.56.32.png
Jeff Barton Non-Executive Director

Jeff recently retired as Vice President, Licencing and Acquisitions at Abbott Laboratories but has continued to serve as Abbott’s nominated Director on the Board while Abbott searches for a replacement. During his career at Abbott, Jeff held a variety of financial management positions, including in Diagnostics, Nutrition and Pharmaceuticals.


External Appointments
None

N

Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee

JP8_4707_CEO.jpg
Manuel Llobet Chief Executive Officer

Manuel has been CEO of Allergy Therapeutics plc since 2009, shaping strategy and driving growth. Prior to this, Manuel was the Principal Consultant for Biohealth LLC and CEO of International Operations of the Weinstein family’s group of companies.

External Appointments
None


Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee

Screen Shot 2018-03-19 at 13.51.23.png
Nick Wykeman Chief Finance Officer

Nick joined Allergy Therapeutics plc in 2016 as Finance Director. He leads the finance function developing and implementing financial strategy. Nick is a Chartered Accountant and previously held positions at Skyepharma PLC (now part of Vectura Group plc) and Quest International (a division of ICI PLC)

External Appointments
None

Key to Committees
A Audit Committee
N Nomination Committee
R Remuneration Committee
* Denotes Chairman of a Committee